AMGN
AMGEN INC
NASDAQ · Healthcare · Drug Manufacturers - General · US
$385.65
+1.55%Forward multiples
Based on analyst estimates
- P/E forward
- 16.46x
- P/E 2026E
- 16.61x
- P/E 2027E
- 15.69x
- P/E 2028E
- 14.89x
- P/S forward
- 5.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.78x
- PEG TTM
- 0.53x
- Price / book
- 17.84x
- Price / sales
- 5.47x
- Price / cash flow
- 16.71x
Enterprise value
- Enterprise value
- $251.8B
- EV / sales
- 6.60x
- EV / EBITDA
- 15.25x
- EV / EBIT
- 19.91x
- Market cap
- $208.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026